Location · New Haven, CT
Clinical trials in New Haven, CT
189 recruiting studies have a site in New Haven, and 88 of them accept healthy volunteers.
189 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 1/Phase 2
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With…
Cabaletta Bio
- Location
- New Haven, CT + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- New Haven, CT + 131 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Accuro XV Ultrasound Imaging System for BoneEnhance and Fracture Detection Algorithms
Rivanna Medical, Inc.
- Location
- New Haven, CT + 9 other US sites
- Eligibility basics
- Ages 5+
- RecruitingPhase 3
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
H. Lundbeck A/S
- Location
- New Haven, CT + 13 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Boehringer Ingelheim
- Location
- New Haven, CT + 154 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)
Angitia Incorporated Limited
- Location
- New Haven, CT + 5 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Akero Therapeutics, Inc
- Location
- New Haven, CT + 130 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Cytokinetics
- Location
- New Haven, CT + 80 other US sites
- Eligibility basics
- Ages 18–85
- Recruiting
Onyx™ Liquid Embolic IDE Clinical Study
Medtronic Endovascular
- Location
- New Haven, CT + 19 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 1/Phase 2
A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal Toxicity
Azitra Inc.
- Location
- New Haven, CT + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Sanofi
- Location
- New Haven, CT + 33 other US sites
- Eligibility basics
- Ages 1–25
- Recruiting
The ArtixASCEND Study
Inari Medical
- Location
- New Haven, CT + 22 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Cook Research Incorporated
- Location
- New Haven, CT + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Hoffmann-La Roche
- Location
- New Haven, CT + 5 other US sites
- Eligibility basics
- Ages 18+ · Men only
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- New Haven, CT + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
Gilead Sciences
- Location
- New Haven, CT + 11 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs).
Medtronic Neurovascular Clinical Affairs
- Location
- New Haven, CT + 24 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
Dianthus Therapeutics
- Location
- New Haven, CT + 29 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Pegtibatinase as a Treatment for Participants With Classical Homocystinuria (HCU) Receiving Standard of Care Treatment
Travere Therapeutics, Inc.
- Location
- New Haven, CT + 11 other US sites
- Eligibility basics
- Ages 12–65
- Recruiting
The PERSEVERE Study
Inari Medical
- Location
- New Haven, CT + 15 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Regeneron Pharmaceuticals
- Location
- New Haven, CT + 55 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
Eli Lilly and Company
- Location
- New Haven, CT + 19 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study of Brenipatide in Adult Participants With Schizophrenia
Eli Lilly and Company
- Location
- New Haven, CT + 31 other US sites
- Eligibility basics
- Ages 18–55
- RecruitingPhase 2
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Calico Life Sciences LLC
- Location
- New Haven, CT + 33 other US sites
- Eligibility basics
- Ages 18–55